公司资料
Cybin 股价、新闻与催化剂
- 股票代码:
- CYBN
- 交易所:
- AMEX
- 行业:
- Biopharma
- 所在地:
- Canada and listed in the U
股价为何变动
Current closing-price context is not available for CYBN.
公司概览
业务概览
Cybin is a biotechnology company focused on psychedelic-inspired mental health therapeutics. Its story is built around developing new treatments for depression and other psychiatric conditions through psychedelic-derived science.
所在地与行业分类
Cybin is headquartered in Canada and listed in the U.S. market. It sits in neuroscience biotechnology with a novel-therapeutics profile.
商业模式特征
The company depends on clinical validation, regulatory progress, and the ability to translate a new therapeutic paradigm into real-world value. Investors usually watch early data, trial design, and capital runway.
生物医药行业定位
Cybin occupies a speculative but highly visible neuroscience niche within biotech. The stock is sensitive to whether psychedelic-inspired therapy can turn into a durable clinical category.
未来催化剂
- Cybin’s catalysts are psychedelic-neuroscience programs, especially CYB003 and CYB004, where the next clinical or regulatory update can materially move sentiment. The company is still highly dependent on proof of concept.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。